Literature DB >> 9336848

1H, 13C, and 15N backbone assignment and secondary structure of the receptor-binding domain of vascular endothelial growth factor.

W J Fairbrother1, M A Champe, H W Christinger, B A Keyt, M A Starovasnik.   

Abstract

Nearly complete sequence-specific 1H, 13C, and 15N resonance assignments are reported for the backbone atoms of the receptor-binding domain of vascular endothelial growth factor (VEGF), a 23-kDa homodimeric protein that is a major regulator of both normal and pathological angiogenesis. The assignment strategy relied on the use of seven 3D triple-resonance experiments [HN(CO)CA, HNCA, HNCO, (HCA)CONH, HN(COCA)HA, HN(CA)HA, and CBCA-(CO)NH] and a 3D 15N-TOCSY-HSQC experiment recorded on a 0.5 mM (12 mg/mL) sample at 500 MHz, pH 7.0, 45 degrees C. Under these conditions, 15N relaxation data show that the protein has a rotational correlation time of 15.0 ns. Despite this unusually long correlation time, assignments were obtained for 94 of the 99 residues; 8 residues lack amide 1H and 15N assignments, presumably due to rapid exchange of the amide 1H with solvent under the experimental conditions used. The secondary structure of the protein was deduced from the chemical shift indices of the 1H alpha, 13C alpha, 13C beta, and 13CO nuclei, and from analysis of backbone NOEs observed in a 3D 15N-NOESY-HSQC spectrum. Two helices and a significant amount of beta-sheet structure were identified, in general agreement with the secondary structure found in a recently determined crystal structure of a similar VEGF construct [Muller YA et al., 1997, Proc Natl Acad Sci USA 94:7192-7197].

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9336848      PMCID: PMC2143562          DOI: 10.1002/pro.5560061020

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  29 in total

1.  Discovering high-affinity ligands for proteins: SAR by NMR.

Authors:  S B Shuker; P J Hajduk; R P Meadows; S W Fesik
Journal:  Science       Date:  1996-11-29       Impact factor: 47.728

2.  Crystallization of the receptor binding domain of vascular endothelial growth factor.

Authors:  H W Christinger; Y A Muller; L T Berleau; B A Keyt; B C Cunningham; N Ferrara; A M de Vos
Journal:  Proteins       Date:  1996-11

Review 3.  The cystine-knot growth-factor superfamily.

Authors:  P D Sun; D R Davies
Journal:  Annu Rev Biophys Biomol Struct       Date:  1995

4.  Secondary structure of beta-hydroxydecanoyl thiol ester dehydrase, a 39-kDa protein, derived from H alpha, C alpha, C beta and CO signal assignments and the Chemical Shift Index: comparison with the crystal structure.

Authors:  V Copié; J A Battles; J M Schwab; D A Torchia
Journal:  J Biomol NMR       Date:  1996-06       Impact factor: 2.835

5.  Vascular endothelial growth factor is a secreted angiogenic mitogen.

Authors:  D W Leung; G Cachianes; W J Kuang; D V Goeddel; N Ferrara
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

6.  1H, 13C and 15N chemical shift referencing in biomolecular NMR.

Authors:  D S Wishart; C G Bigam; J Yao; F Abildgaard; H J Dyson; E Oldfield; J L Markley; B D Sykes
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

7.  Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.

Authors:  J Waltenberger; L Claesson-Welsh; A Siegbahn; M Shibuya; C H Heldin
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

Review 8.  The role of vascular endothelial growth factor in pathological angiogenesis.

Authors:  N Ferrara
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

9.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.

Authors:  P Carmeliet; V Ferreira; G Breier; S Pollefeyt; L Kieckens; M Gertsenstein; M Fahrig; A Vandenhoeck; K Harpal; C Eberhardt; C Declercq; J Pawling; L Moons; D Collen; W Risau; A Nagy
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  3 in total

1.  1H, 13C, and 15N resonance assignment of the vascular endothelial growth factor receptor-binding domain in complex with a receptor-blocking peptide.

Authors:  Borlan Pan; Wayne J Fairbrother
Journal:  J Biomol NMR       Date:  2002-02       Impact factor: 2.835

2.  Complete 1H, 13C and 15N backbone assignments for the hepatitis A virus 3C protease.

Authors:  T C Bjorndahl; M S Watson; C M Slupsky; L Spyracopoulos; B D Sykes; D S Wishart
Journal:  J Biomol NMR       Date:  2001-02       Impact factor: 2.835

3.  Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth Factor.

Authors:  Núria Bayó-Puxan; Ricard Rodríguez-Mias; Michael Goldflam; Martin Kotev; Sonia Ciudad; Christopher J Hipolito; Monica Varese; Hiroaki Suga; Ramón Campos-Olivas; Xavier Barril; Víctor Guallar; Meritxell Teixidó; Jesús García; Ernest Giralt
Journal:  ChemMedChem       Date:  2015-11-10       Impact factor: 3.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.